This week, vaccine manufacturer Moderna revealed that Vinaya Prasad, the top vaccine regulator at the Food and Drug Administration (FDA)—which is a part of HHS— declined to even consider the safety ...

On Feb. 10, pharmaceutical company Moderna announced that the FDA Center for Biologics Evaluation and Research (CBER) had refused to review its application to market an investigational mRNA-based flu ...

At issue with Moderna's mRNA flu shot is communication from CBER to Moderna suggesting that the company’s vaccine be compared against a control shot designed more specifically for older people.

Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.

Professor Chad Mirkin found that the vaccine’s carefully organized structure dramatically boosts cancer-fighting immunity.

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...

In a winter marked by flu outbreaks, the persistence of COVID-19, and surges of measles cases across the United States, an Annenberg survey finds that a sizable majority of Americans think the three ...

ETHealthworld.com brings latest serum institute of india news, views and updates from all top sources for the Indian Health industry.

The biotech’s licensing pact with Pfizer, revealed last week, will leverage its adjuvant vaccine platform in the development of two undisclosed Pfizer products. After pocketing ...

A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London, on Oct. 7, 2020. (Alastair Grant/AP) RICHMOND, Va. (CN) — A Fourth ...

Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing Pfizer (PFE.N), opens new tab access to its technology that boosts immune responses to vaccines ‌for use in up to ...